EnerSys jumped 6% on a big fiscal-Q1 beat and a defense-cell DOE grant, while Ondas gave back 9% as a record-revenue quarter ran into skepticism over the second-half ramp its guidance requires.

The batteries chokepoint led the tape. EnerSys rose +5.7% to $197.38 after reporting fiscal Q1 2027 results (out Tuesday after the close) that beat hard: net sales of $936 million, up 5%, with gross margin expanding 510 basis points to 33.5%, diluted EPS of $3.09 more than doubling year-on-year, and adjusted EPS of $3.66 topping the Street by roughly 84 cents. Management raised its Q2 guide, lifted the dividend 10% to $0.2875, and finalized a Department of Energy grant supporting a defense-focused lithium-cell plant in Greenville, South Carolina. For a drone and counter-UAS supply chain, stored energy is the chokepoint where endurance and mission time are set — every airframe, ground station and directed-energy effector runs on cells — and a domestic, defense-qualified cell line with federal backing is exactly the kind of onshore capacity the vertical's thesis wants to see funded.

The laggard was an airframe name punished for a good quarter. Ondas fell −8.8% to $8.91 after reporting Q2 before Thursday's open: record revenue of $83.8 million, up 67% sequentially and roughly thirteen times a year ago, beating the roughly $68 million consensus, with the loss near $0.06 a share. But adjusted EBITDA loss widened to $50.6 million, gross margin slipped to 43.1% from 49.2%, and with management raising the full-year guide to $525–550 million, the market balked at the roughly $400 million of second-half revenue that target implies. It read as a classic sell-the-news: at the airframes-and-compliant-supply chokepoint, order momentum is real, but the path from record bookings to profitability is the part investors chose to discount.

Elsewhere the basket split along its chokepoints. At the rare-earth-magnet layer that feeds every drone motor and actuator, MP Materials rose +2.9% to $55.66 on reports of a new long-term agreement to supply separated gadolinium to a US aerospace-and-defense customer, extending its heavy-rare-earth reach beyond the NdPr that anchors its business. The other battery names were mixed — Ultralife +3.0% to $7.44 drifting higher after its own quarter, but Enovix −6.3% to $4.43 falling as its Q2 print pushed the flagship smartphone-cell qualification out to end-2026, keeping the key use case pre-revenue. The infrared-optics choke gave back after a strong run, LightPath −4.4% to $13.12 on profit-taking with no fresh headline, and Umicore's US line eased −4.2% to $6.65 with no company-specific catalyst.

The demand calendar is dense into late August. The Pentagon's "Gauntlet II" drone-dominance final competition and production down-select — a $300 million-plus buy of up to roughly 60,000 NDAA-compliant drones — is targeted around August 24, the clearest near-term demand signal for compliant airframes and components. Commercial UAV Expo convenes in Las Vegas September 1–3, the venue where Part 108 BVLOS positioning and new orders tend to surface, and LightPath reports fiscal Q4 around September 10 to test whether its infrared design wins are converting to a revenue ramp. The hard policy date still hanging over the rare-earth names is November 10, when China's one-year suspension of its rare-earth export controls expires.